Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2023 11:30 ET | Source: St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital Unveils The Domino’s Village

Memphis, Tenn., Sept. 27, 2023 (GLOBE NEWSWIRE) -- St. Jude Children’s Research Hospital® and Domino’s®, the largest pizza company in the world, today unveiled The Domino’s Village, a multi-million...
September 12, 2023 09:00 ET | Source: ALS Society of Canada

Empowering Resilience and Academic Pursuits

TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The ALS Society of Canada (ALS Canada) and the Kevin Daly Bursary Fund are pleased to announce the recipients of the 2023 ALS Canada Kevin Daly Bursary,...
August 25, 2023 08:45 ET | Source: Proto

Proto Hologram to Launch First AI Holograms for Enterprise

Los Angeles, CA, Aug. 25, 2023 (GLOBE NEWSWIRE) -- Proto Inc., the leader in holographic visual computing, announced today the September 8th launch of ProtoGPT: Conversational AI Avatar Holograms...
August 16, 2023 12:19 ET | Source: Visory Health

UPDATE – Visory Health’s Rapid Growth Leads Parent Company, XIL Health, to Become Three-Time Inc. 5000 Honoree

ORLANDO, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Visory Health, a women-led, patient-first healthtech prescription platform that is transforming the way women, families and caregivers access...
August 16, 2023 09:00 ET | Source: Visory Health

Visory Health’s Rapid Growth Leads Parent Company, XIL Health, to Become Three-Time Inc. 5000 Honoree

ORLANDO, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Visory Health, a women-led, patient-first healthtech prescription platform that is transforming the way women, families and caregivers access...
August 09, 2023 21:07 ET | Source: 10X Capital Venture Acquisition Corp. III

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV infection and depletion, thus allowing those...
August 09, 2023 19:02 ET | Source: 10X Capital Venture Acquisition Corp. III

Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III

Addimmune’s investigational cell therapy, AGT103-T, makes gene modifications to the patients’ immune cells (T cells) that harden those cells against HIV infection and depletion, thus allowing those...
August 03, 2023 10:00 ET | Source: SoldierStrong

Soldierstrong Awards Soldierscholar Scholarship to Navy Seal in Georgetown University Master’s Program

STAMFORD, Conn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- A U.S. Navy SEAL who will begin his studies this fall to earn a master’s degree from Georgetown University is the latest recipient of a...
July 19, 2023 05:00 ET | Source: CONSEGIC BUSINESS INTELLIGENCE PRIVATE LIMITED

Veterinary Diagnostic Imaging Market to Hit US$ 2,023.16 Million By 2030

New York, July 19, 2023 (GLOBE NEWSWIRE) -- The global Veterinary Diagnostic Imaging Market is expected to witness significant growth at a remarkable CAGR of 6.3% during the forecast period of...
July 18, 2023 08:30 ET | Source: 3D Systems Inc.

Matrix Moon Accelerating Additive Manufacturing in India with 3D Systems EXT Titan Pellet 3D Printer

Matrix Moon first in India to install EXT Titan Pellet 3D printer, pioneering manufacturing transformationSelected 3D Systems EXT 1070 Titan Pellet systems to deliver tremendous cost & time...